Asacol HD Alternatives Compared
| Asacol HD (mesalamine) | Entyvio (vedolizumab) | Pentasa (mesalamine) |
|
|---|
| Asacol HD (mesalamine) | Entyvio (vedolizumab) | Pentasa (mesalamine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ulcerative Colitis - Maintenance, Ulcerative Colitis - Active, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Proctitis. Asacol HD may also... View more |
Prescription only
Entyvio infusion is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically... View more |
Prescription only
Prescribed for Ulcerative Colitis - Maintenance, Ulcerative Colitis - Active, Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Proctitis. Pentasa may also be... View more |
Related suggestions Ulcerative Colitis
Crohn's Disease, Maintenance
Popular comparisons
|
|||||||||||||||
| More about Asacol HD (mesalamine) | More about Entyvio (vedolizumab) | More about Pentasa (mesalamine) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Asacol HD has an average rating of 8.9 out of 10 from a total of 9 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 0% reported a negative effect. |
Entyvio has an average rating of 6.3 out of 10 from a total of 164 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 28% reported a negative effect. |
Pentasa has an average rating of 7.7 out of 10 from a total of 89 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 10% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Asacol HD side effects |
View all Entyvio side effects |
View all Pentasa side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
| Lower cost generic approved |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Entyvio prices |
View all Pentasa prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other mesalamine brands include: Apriso, Asacol, Canasa, Canasa Pac, Delzicol, Lialda, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | Other vedolizumab brands include: Entyvio Pen | Other mesalamine brands include: Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
10 hours |
600 hours |
10 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 121 drugs are known to interact with Asacol HD:
|
A total of 165 drugs are known to interact with Entyvio:
|
A total of 121 drugs are known to interact with Pentasa:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
May 29, 2008 |
May 20, 2014 |
May 10, 1993 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Medrol
Medrol is used for allergic rhinitis, asthma, asthma, acute, asthma, maintenance, congenital ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Medrol Dosepak
Medrol Dosepak is used for allergic rhinitis, asthma, asthma, acute, asthma, maintenance, atopic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.